OKYO
OKYO Pharma
OKYO
OKYO
6 hedge funds and large institutions have $1.36M invested in OKYO Pharma in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$145K |
| 2 |
Cerity Partners
New York
|
+$1.49K |
| 3 |
CA
Continuum Advisory
Eagle,
Idaho
|
+$76 |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$49K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21.7K |
| 3 |
Renaissance Technologies
New York
|
-$21K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| $1.28M | +$145K | +97,554 | +13% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $30.5K | -$21.7K | -14,474 | -42% |
|
3
HSBC Holdings
London,
United Kingdom
| $20.3K | – | – | – |
|
|
4
Cerity Partners
New York
| $19.8K | +$1.49K | +1,000 | +8% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $18.1K | – | – | – |
|
|
CA
6
Continuum Advisory
Eagle,
Idaho
| $76 | +$76 | +50 | New |
|
|
7
Morgan Stanley
New York
| – | -$49K | -27,692 | Closed |
|
|
8
Renaissance Technologies
New York
| – | -$21K | -11,800 | Closed |
|